Cedar Hill Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Cedar Hill Associates's JNJ Position: Q4 2018 in Review
Cedar Hill Associates reduced its Johnson & Johnson (JNJ) stake by 25% in Q4 2018, selling an estimated $177K and leaving 3,815 shares worth $492K. The position accounts for 0.19% of the portfolio, ranked #79.
Cedar Hill Associates first reported a position in JNJ in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.98M in Q4 2017. 2,764 funds tracked by Wall St. Rank hold JNJ as of Q4 2018.
- Cedar Hill Associates held 3,815 shares of Johnson & Johnson worth $492K as of Q4 2018.
- Cedar Hill Associates sold 1,269 Johnson & Johnson shares in Q4 2018, an estimated $177K.
- Johnson & Johnson made up 0.19% of Cedar Hill Associates's portfolio in Q4 2018, its #79 holding.
- Cedar Hill Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 23 quarters since.
- Cedar Hill Associates's Johnson & Johnson position peaked at $1.98M in Q4 2017.
- 2,764 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2018.
Based on Cedar Hill Associates's 13F filing for Q4 2018, filed 13 Feb 2019.